Showing 4611-4620 of 5964 results for "".
- Revian Awarded Patent for Biostimulatory Light Combinationshttps://practicaldermatology.com/news/revian-awarded-patent-for-biostimulatory-light-technology/2460249/Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the u
- Amorepacific Shows Off Face Mask 3D Printing System and Flexible LED Beauty Device at CES 2020https://practicaldermatology.com/news/amorepacific-shows-off-face-mask-3d-printing-system-and-flexible-led-beauty-device-at-ces-2020/2460246/Amorepacific is presenting its 3D face mask printing system (IOPE Tailored 3D Mask) and flexible LED beauty device (MakeON Flexible LED Patch) at the Consumer Electronics Show 2020 (CES 2020) in Las Vegas. Created in collaboration with the 3D printing system developer Lincsolu
- DermWire Exclusive: Meet Allē, Allergan’s Upgraded Patient Loyalty Programhttps://practicaldermatology.com/news/dermwire-exclusive-meet-alle-allergans-upgraded-patient-loyalty-program/2460244/Allergan’s Brilliant Distinctions customer loyalty program is getting a facelift in honor of its 2nd decade. The program is smarter, faster and now goes by Allē. It’s much more than a new name, shares Carrie Strom, Allergan’s Senior Vice President o
- Study of Victoria's Secret Models Highlights Changing and Unattainable Beauty Standardshttps://practicaldermatology.com/news/study-of-victorias-secret-models-highlights-changing-and-unattainable-beauty-standards/2460242/While the average American woman's waist circumference and dress size has increased over the past 20 years, Victoria's Secret fashion models have become more slender, with a decrease in bust, waist, hips and dress size, though their waist to hip ratio (WHR) has remained constant, accordin
- DermTech’s Pigmented Lesion Assay Receives Medicare Coveragehttps://practicaldermatology.com/news/dermtechs-pigmented-lesion-assay-receives-medicare-coverage/2460241/The Medicare Administrative Contractor Palmetto GBA MolDx issued a final local coverage determination for DermTech, Inc.'s Pigmented Lesion Assay (PLA). The PLA test is used to help rule out primary cutaneous melanoma and guide biopsy decisions of melanocytic skin lesions with one or more cli
- Ortho Dermatologics Expands Solta Medical Team with New Hireshttps://practicaldermatology.com/news/ortho-dermatologics-expands-solta-medical-team-with-new-hires/2460237/Ortho Dermatologics is staffing up its Solta Medical business unit. The new appointments include the following: Liz Newman, General Manager, Solta, North America Newman first joined Solta in January 2018 as se
- Castle Creek Completes Acquisition of Fibrocell Sciencehttps://practicaldermatology.com/news/castle-creek-completes-acquisition-of-fibrocell-science/2460235/Castle Creek Pharmaceutical Holdings, Inc. completed the acquisition of Fibrocell Science, Inc. Both companies have advanced investigational therapies for the treatment of epidermolysis bullosa (EB) into late-stage clinical research. Prior to the acquisition, Fibrocell initiated a pivot
- Defective Stem Cell Behavior Linked to Psoriasishttps://practicaldermatology.com/news/defective-stem-cell-behavior-linked-to-psoriasis/2460233/Investigators from
- Cutera Rolls Out Heroes Among Us Programhttps://practicaldermatology.com/news/cutera-rolls-out-heroes-among-us-program/2460228/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical Forum (CUCF) in Scott
- NavaDerm Partners Adds Dan Wechsler as Executive Chairmanhttps://practicaldermatology.com/news/navaderm-partners-adds-dan-wechsler-as-executive-chairman/2460225/Dan Wechsler is the new Executive Chairman of NavaDerm Partners, a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm. Wechs